Using their initial study population of nine high-risk breast cancer patients, who had previously tested negative for BRCA1 and BRCA2 mutations, Sun et al. identified RECQL mutations in two patients, prompting them to further investigate the gene. The gene discussed is BRCA1; the disease is breast carcinoma.